Capital Flow Monitor · Sponsors · CIK 2111997
Verra Therapeutics, Inc.
1939 EAST SHORE DR. SUITE 5, LANSING, NY, 14882 · 607 227 6828
Biotechnology · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$450K
Sold
$205K
% sold
45.6%
Investors
6
Min investment
$10K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-02-18 | D ·current | 506(b) | $450K | $205K | 45.6% | 6 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Christopher Lucas Prince — Director, Lansing, NY
- Christopher Lucas Prince — Executive Officer, Lansing, NY
- Christopher Lucas Prince — Director, Lansing, NY
- Jeffrey Calkins — Director, Lansing, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.